Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways

International Journal of Oncology

Volumn 40, Issue 1, 2012, Pages 203-208

  Waiwut, Pornthip ^a   Inujima, Akiko ^a   Inoue, Hiroki ^a   Saiki, Ikuo ^a   Sakurai, Hiroaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bid; STAT1; TNF ; TRAIL

Indexed keywords

BUFADIENOLIDE; BUFOTALIN; CASPASE 3; DEATH RECEPTOR 5; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL XL; PROTEIN BID; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SMALL INTERFERING RNA; STAT1 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VENOM; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL DEATH; CHEMICAL STRUCTURE; CHINESE MEDICINE; ENZYME ACTIVATION; HELA CELL; PRIORITY JOURNAL; TOAD; TRADITIONAL MEDICINE;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BUFANOLIDES; DRUG SYNERGISM; HELA CELLS; HUMANS; PHOSPHORYLATION; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84455174465     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1182     Document Type: Article

References (25)

1. Fulda S and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811, 2006. (Pubitemid 44187627)
2. Ding WX and Yin XM: Dissection of the multiple mechanisms of TNF-alpha induced apoptosis in liver injury. J Cell Mol Med 8: 445-454, 2004.
3. Smith CA, Farrah T and Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962, 1994. (Pubitemid 24106376)
4. Kantari C and Walczak H: Caspase-8 and Bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta 1813: 558-563, 2011.
5. Chen X, Ding WX, Ni HM, Gao W, Shi YH, Gambotto AA, Fan J, Beg AA and Yin XM: Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injury. Mol Cell Biol 27: 541-553, 2006.
6. Perez D and White E: TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol Cell 6: 53-63, 2000.
7. Stevenson HS, Fu SW, Pinzone JJ, Rheey J, Simmens SJ and Berg PE: BP1 transcriptionally activates bcl-2 and inhibits TNFalpha-induced cell death in MCF7 breast cancer cells. Breast Cancer Res 9: R60, 2007.
8. Pei Y, Xing D, Gao X, Liu L and Chen T: Real-time monitoring full length bid interacting with Bax during TNF-alpha-induced apoptosis. Apoptosis 12: 1681-1690, 2007. (Pubitemid 47106891)
9. Alvarez S, Blanco A, Fresno M and Muñoz-Fernández MÁ: TNF-α contributes to caspase-3 independent apoptosis in neuroblastoma cells: role of NFAT. PLoS One 6: e16100, 2011.
10. Thorburn A, Behbakht K and Ford H: TRAIL receptor-targeted therapeu-tics: resistance mechanisms and strategies to avoid them. Drug Resist Updat 11: 17-24, 2008.
11. Xu W, Luo H, Zhang Y, Shan L, Li H, Yang M, Liu R and Zhang W: Simultaneous determination of five main active bufadienolides of Chan Su in rat plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 859: 157-163, 2007. (Pubitemid 350046447)
12. Puschett JB, Agunanne E and Uddin MN: Emerging role of the bufadienolides in cardiovascular and kidney diseases. Am J Kidney Dis 56: 359-370, 2010.
13. Li J, Ma X, Li F, Wang J, Chen H, Wang G, Lv X, Sun C and Jia J: Preparative separation and purification of bufadienolides from Chinese traditional medicine of ChanSu using high-speed counter-current chromatography. J Sep Sci 33: 1325-1330, 2010.
14. Nogawa T, Kamano Y, Yamashita A and Pettit GR: Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su. J Nat Prod 64: 1148-1152, 2001. (Pubitemid 32937882)
15. Ye, M.and Guo DA: Analysis of bufadienolides in the Chinese drug ChanSu by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrom-etry. Rapid Commun Mass Spectrom 19: 1881-1892, 2005.
16. Su CL, Lin TY, Lin CN and Won SJ: Involvement of caspases and apoptosis-inducing factor in bufotalin-induced apoptosis of Hep 3B cells. J Agric Food Chem 57: 55-61, 2009.
17. Watabe M, MasudaY, Nakajo S, Yoshida T, Kuroiwa Y and Nakaya K: The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem 271: 14067-14072, 1996.
18. Luo J, Kamata H and Karin M: IKK/NF-κB signaling: balancing life and death- a new approach to cancer therapy. J Clin Invest 115: 2625-2632, 2005. (Pubitemid 41434385)
19. Garcia-Fernandez LF, Losada A and Alcaide V: Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase Cy. Oncogene 21: 7533-7544, 2002. (Pubitemid 35305581)
20. Capano M and Crompton M: Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J 395: 57-64, 2006.
21. Deng Y, Ren X, Yang L, Lin Y and Wu X: A JNK-dependent pathway is required for TNF-induced apoptosis. Cell 115: 61-70, 2003. (Pubitemid 37255318)
22. Lin FL, Hsu JL, Chou CH, Wu WJ, Chang CI and Liu HJ: Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways. Eur J Pharmacol 650: 120-129, 2011.
23. Nordström E, Fisone G and Kristensson K: Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells. FASEB J 23: 613-622, 2008.
24. Nesterov A, Nikrad M, Johnson T and Kraft AS: Oncogenic ras sensitizes normal human cells to tumor necrosis factor-α-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 64: 3922-3927, 2004. (Pubitemid 38697305)
25. Carlisi D, D'Anneo A, Angileri L, Lauricella M, Emanuele S, Santulli A, Vento R and Tesoriere G: Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. J Cell Physiol 226: 1632-1641, 2010.